RBFOX2
protein-codingRNA binding fox-1 homolog 2, the group of RNA binding motif containing
Gene summary
This gene is one of several human genes similar to the C. elegans gene Fox-1. This gene encodes an RNA binding protein that is thought to be a key regulator of alternative exon splicing in the nervous system and other cell types. The protein binds to a conserved UGCAUG element found downstream of many alternatively spliced exons and promotes inclusion of the alternative exon in mature transcripts. The protein also interacts with the estrogen receptor 1 transcription factor and regulates estrogen receptor 1 transcriptional activity. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
- RBM9
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~290.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0000119
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0005453
Submitter: ClinGen
*RBFOX2* was first reported in relation to autosomal dominant congenital heart disease in 2015 (Homsy et al., PMID: 26785492). At least 5 rare variants (1 missense, 4 loss-of-function) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. *RBFOX2* has been noted to be associated with the following disease entities: aortic stenosis/atresia, atrial septal defects, double outlet right ventricle, hypoplastic aortic arch, and hypoplastic left ventricle (OMIM 619657). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism and inheritance pattern. Therefore, these disease entities have been lumped into one disease entity, Autosomal Dominant RBFOX2-related Congenital Heart Disorders. Variants in this gene have been reported in at least 5 probands in 2 publications from the same research consortium (PMIDs 26785492, 28991257), using an allele frequency threshold of 1x10-5. This gene-disease relationship is supported by animal models, expression studies, and functional assays. Expression studies confirmed that *RBFOX2* is expressed during zebrafish embryogenesis (PMID 21925157), mouse embryogenesis (PMID 31241461) and in rat cardiac myoblasts (PMID 24151077). Depletion of Rbfox2 in rat cardiac myoblasts mouse cardiomyocytes led to aberrant splicing of target mRNAs (PMIDs 31241461, 31778749). Multiple zebrafish models demonstrated abnormal cardiac development after depletion of rbfox2 and rbfox1l, with rescue of the ventricular hypoplasia after introduction of rbfox2 mRNA (PMIDs 21925157, 36198703). Mouse embryos deficient for Rbfox2 resulted in thin ventricular walls (PMID 35137168). In summary, there is strong evidence to support this gene-disease relationship. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date 3/5/24 (SOP Version 10).
Inheritance Pattern: AD
Disease ID:MONDO:0100557
Submitter: PanelApp Australia
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to RBFOX2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001349999.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 31 | 5 | 36 | |||
| missense | 1 | 67 | 1 | 1 | 70 | |
| nonsense | 1 | 2 | 3 | |||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 2 | 3 | |||
| splice donor/acceptor (+/-2bp) | 4 | 4 | ||||
| Total | 3 | 2 | 74 | 32 | 6 | 117 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001336928.2 | 14 | MANE Select | |
| Ensembl | ENSP00000512219.1 | 14 | MANE Select | |
| RefSeq | NP_001026865.1 | 13 | Standard | |
| RefSeq | NP_001076045.1 | 13 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| rbfox2 | Danio rerio | Structure: skeletal muscle Quality: decreased force abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- FGFR2 alternative splicing
- Signaling by FGFR2
- Signal Transduction
- Signaling by FGFR
- Signaling by Receptor Tyrosine Kinases
Biological Process
- regulation of alternative mRNA splicing, via spliceosome
- mRNA processing
- nervous system development
- RNA splicing
- fibroblast growth factor receptor signaling pathway
Molecular Function
- transcription corepressor activity
- RNA binding
- mRNA binding
- protein binding
- transcription factor binding
Cellular Component
- nucleus
- nucleoplasm
- cytoplasm
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000438146
- Coding exons
- 14
- Length
- 289691
- Individuals with no LoFs
- 124485
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 124486
- p
- 0.00000402
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.58 | 144 | 262 | 0.550 | 0.0000161 | 2844 |
| Missense (PolyPhen) | 39 | 119.69 | 0.32584 | 1201 | ||
| Synonymous | -0.278 | 109 | 105 | 1.03 | 0.00000720 | 935 |
| Loss of Function | 4.40 | 1 | 24.5 | 0.0408 | 0.00000121 | 293 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.0000088 | 0.0000088 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: RNA-binding protein that regulates alternative splicing events by binding to 5'-UGCAUGU-3' elements. Prevents binding of U2AF2 to the 3'-splice site. Regulates alternative splicing of tissue-specific exons and of differentially spliced exons during erythropoiesis (By similarity). RNA-binding protein that seems to act as a coregulatory factor of ER-alpha. {ECO:0000250, ECO:0000269|PubMed:11875103}.;
Recessive Scores
- pRec
- 0.0922
Intolerance Scores
- RVIS EVS
- -0.43
- RVIS percentile EVS
- 25.15
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.114
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |